EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vitro human hepatocyte incubation of 5F-MDMB-PINACA, 5F-MDMB-PICA, 5F-EMDB-PICA, 4F-MDMB-BICA, and 4F-MDMB-BINACA and cannabinoid receptor 1 activity profiling of major human metabolites

Darta Stalberga, Manuela Carla Monti, Tobias Rautio, Wies Euwals, Huiling Liu, Xiongyu Wu, Johan Dahlen, Mattias Persson, Henrik Green

Archives of Toxicology · 13.11.2026

DOI: 10.1007/s00204-026-04625-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Toxicology, online erschienen am 13.11.2026. Verfasst von Darta Stalberga und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Chemistry and Pharmacology, Department of Biomedical and Clinical Sciences, Faculty of Medicine, Linköping University, Linköping…. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Linköping University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since their first reported fatalities in 2016, fluorinated MDMB-group synthetic cannabinoid receptor agonists (SCRAs), 5F-MDMB-PINACA, 5F-MDMB-PICA, 5F-EDMB-PICA, 4F-MDMB-BICA, and 4F-MDMB-BINACA, have remained present on illegal drug markets. Detection of SCRAs in clinical and forensic casework relies on metabolite detection, yet confirmation using metabolite reference standards is often lacking. Moreover, limited knowledge is available regarding the metabolites’ activity at the cannabinoid 1 receptor (CB 1 ) and their potential contribution to cannabinoid pharmacology and toxicology. Therefore, this work aimed to confirm major metabolites of the five analogue SCRAs using in-house-synthesized reference standards and evaluate their activity at the CB 1 receptor. SCRAs (5 µM) were incubated for 3 h with human hepatocytes, and supernatants were analyzed by high-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry (HPLC-QToF-MS), and spectra were compared with reference standards. Parent and metabolite activity were measured using an in vitro recombinant cell AequoScreen ® assay with a concentration range of 0.0286 nM–60 µM. Sixteen of 20 assessed metabolites were confirmed, including major metabolites such as ester hydrolysis (EH), carboxylic acid formation, combinations with oxidative defluorination (OD). Ten major and rapidly formed metabolites, such as hydroxylated metabolites, OD, and EH, showed high to moderate CB 1 potency (EC 50 96.3 nM–8.07 µM), whereas metabolites with multiple biotransformations showed little to no activation. Together, this study confirms several major metabolites using reference standards and characterizes their CB 1 activity, improving confidence in SCRA detection and providing insight into metabolite contribution to cannabinoid-related activity.

Schlagwörter

Stichwörter der Autor:innen

CB1 receptorMetabolismNew psychoactive substancesPharmacologyStructure-activity relationshipSynthetic cannabinoid receptor agonists (SCRAs)

Autor:innen und Institutionen

  • Division of Clinical Chemistry and Pharmacology, Department of Biomedical and Clinical Sciences, Faculty of Medicine, Linköping University, Linköping, 58183, Sweden. darta.stalberga@liu.se.
  • Division of Clinical Chemistry and Pharmacology, Department of Biomedical and Clinical Sciences, Faculty of Medicine, Linköping University, Linköping, 58183, Sweden.
  • Institute of Forensic Medicine, Department of Biomedical Engineering, University of Basel, Basel, Switzerland.
  • Department of Physics, Chemistry and Biology, Linköping University, Linköping, Sweden.
  • Avans University of Applied Sciences, 's-Hertogenbosch, The Netherlands.
  • Chiron AS, Trondheim, Norway.

Förderung

  • Linköping University

Zitieren

APA

Stalberga, D., Monti, M. C., Rautio, T., Euwals, W., Liu, H., Wu, X., Dahlen, J., Persson, M., & Green, H. (2026). In vitro human hepatocyte incubation of 5F-MDMB-PINACA, 5F-MDMB-PICA, 5F-EMDB-PICA, 4F-MDMB-BICA, and 4F-MDMB-BINACA and cannabinoid receptor 1 activity profiling of major human metabolites. Archives of Toxicology. https://doi.org/10.1007/s00204-026-04625-3

Vancouver

Stalberga D, Monti MC, Rautio T, Euwals W, Liu H, Wu X, et al. In vitro human hepatocyte incubation of 5F-MDMB-PINACA, 5F-MDMB-PICA, 5F-EMDB-PICA, 4F-MDMB-BICA, and 4F-MDMB-BINACA and cannabinoid receptor 1 activity profiling of major human metabolites. Archives of Toxicology. 2026. doi:10.1007/s00204-026-04625-3

BibTeX
@article{Stalberga2026,
  author = {Stalberga, Darta and Monti, Manuela Carla and Rautio, Tobias and Euwals, Wies and Liu, Huiling and Wu, Xiongyu and Dahlen, Johan and Persson, Mattias and Green, Henrik},
  title = {In vitro human hepatocyte incubation of 5F-MDMB-PINACA, 5F-MDMB-PICA, 5F-EMDB-PICA, 4F-MDMB-BICA, and 4F-MDMB-BINACA and cannabinoid receptor 1 activity profiling of major human metabolites},
  journal = {Archives of Toxicology},
  year = {2026},
  doi = {10.1007/s00204-026-04625-3}
}
Kostenlos starten →